Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- The chemistry and biology of soluble guanylate cyclase stimulators and activators.Angew Chem Int Ed Engl. 2013; 52: 9442-9462
- Nitric oxide signalling in cardiovascular health and disease.Nat Rev Cardiol. 2018; 15: 292-316
- Vericiguat in patients with heart failure and reduced ejection fraction.N Engl J Med. 2020; 382: 1883-1893
- Dapagliflozin in patients with heart failure and reduced ejection fraction.N Engl J Med. 2019; 381: 1995-2008
- JCS/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure.Circ J. 2021; 85: 2252-2291
- Heart failure drug treatment: the fantastic four.Eur Heart J. 2021; 42: 681-683
- SOCRATES-REDUCED investigators and coordinators. Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the SOCRATES-REDUCED randomized trial.JAMA. 2015; 314: 2251-2262
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.Lancet. 2010; 376: 875-885